Small Pharma
Pipeline of novel patent-protected deuterium-enriched tryptamine compounds for psychedelic-assisted psychotherapy as a rapid onset, sustained treatment for mental health disorders.
Launch date
Employees
Market cap
€33.6m
Enterprise valuation
€25m (Public information from Oct 2023)
Share price
CAD0.15 DMT.V
Company register number 09420724
London England (HQ & founding location)
Authorizing premium user...